International Cricket

Anti-Doping Positive Test Zimbabwe Pacer May 2026: ICC Tribunal

Anjali Iyer 19 May 2026 Updated 19 May 2026 ~5 min read ~961 words

ICC anti-doping testing equipment and medical sample-collection setup at a cricket venue

Share this article

A named Zimbabwe Cricket pace bowler is reportedly facing an ICC anti-doping tribunal process following a positive test result from an in-competition sample taken during the WCL2 March 2026 fixtures. The named bowler, who has been on the periphery of the Zimbabwe senior squad across the past 18 months, was reportedly provisionally suspended on May 8 under Article 7.9 of the ICC anti-doping code. The provisional suspension is automatic following a positive A-sample finding and is not a determination of guilt. The named bowler has the right to request a B-sample analysis and a formal hearing before the ICC anti-doping tribunal. Zimbabwe Cricket has confirmed the provisional suspension and committed to engaging with the formal process.

The framework, the WADA-code structure

The ICC anti-doping code is constructed within the WADA Code framework. The standard process flows through a series of formal stages. The first is sample collection at a designated tournament window. The second is analysis at a WADA-accredited laboratory. The third is the A-sample finding notification, which triggers an automatic provisional suspension under Article 7.9 of the ICC anti-doping code. The fourth is the right to request a B-sample analysis. The fifth is the formal tribunal hearing. The sixth is the determination and sanction, with the right of appeal to the Court of Arbitration for Sport. The standard tribunal timeline is 60 to 90 days from the provisional suspension to the tribunal hearing.

The named-substance and the framework category

The reported positive test was for a substance in the WADA Code S6 category (stimulants and related substances). The specific substance has not been publicly named at the provisional-suspension stage and will not be made public until the formal tribunal hearing. The S6 category includes several substances that can be present in over-the-counter cold-and-flu medications, which has been a frequent factor in cricket-related anti-doping cases over the past five years. The framework provides for reduced sanctions in cases where the player can establish the source of the positive test was a contaminated supplement or a permitted-medication source, but the burden of proof rests with the player.

The tribunal process, the timeline

The named Zimbabwe pacer has reportedly requested a B-sample analysis, which is the standard procedural step. The B-sample analysis is expected to be completed by early June. Assuming the B-sample confirms the A-sample finding, the formal tribunal hearing would be scheduled for early August. The named pacer has the right to legal representation at the tribunal and the right to call witnesses including medical and nutritional experts. The tribunal is composed of three independent legal and medical experts and the hearing is held under closed-door rules. The tribunal's determination is published in summary form, with the full reasoning available to the named player and Zimbabwe Cricket.

The Zimbabwe Cricket response

Zimbabwe Cricket's formal statement, issued on May 9, was measured and procedural. "Zimbabwe Cricket confirms the provisional suspension of the named player under Article 7.9 of the ICC anti-doping code. We are engaging with the formal process and supporting the named player's right to a fair tribunal. Until the tribunal's determination, we will respect the confidentiality of the named player and the process." The Zimbabwe Cricket player-welfare committee has reportedly provided the named pacer with legal-support resources and access to nutritional and medical advice for the tribunal preparation. The Zimbabwe Cricket men's senior squad has been briefed on the inquiry through the formal team-management channels.

The wider anti-doping framework picture

The ICC anti-doping program has been active across the global cricket calendar for over two decades. The current annual program includes approximately 220 in-competition samples and 80 out-of-competition samples across the senior men's and women's playing pool. The annual positive-test rate has been low, with approximately 4 to 6 positive tests reported per year across the past five years. The most common category of finding has been inadvertent contamination from over-the-counter medications. Recent ICC anti-doping cases have produced sanctions ranging from 6-month bans (where the player established a contaminated source) to 4-year bans (where the framework identified intentional doping). The May 2026 Zimbabwe case will be assessed within that framework.

What it means

The provisional suspension of the named Zimbabwe pacer is a procedural step under the ICC anti-doping code and is not a determination of guilt. The formal tribunal hearing in early August will assess the framework category of the positive test and the named player's explanation. The reported expected outcome window is mid-to-late September. Zimbabwe Cricket's response has been procedurally measured and the named pacer's tribunal preparation is underway. The wider framework, the proactive ICC anti-doping monitoring and the WADA-code structure, will produce the formal determination. Watch the B-sample analysis outcome and the formal tribunal scheduling. The case is in the formal anti-doping process.